Rebastinib
- Generic Name
- Rebastinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C30H28FN7O3
- CAS Number
- 1020172-07-9
- Unique Ingredient Identifier
- 75017Q6I97
- Background
Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath